Biomedical Innovations to Combat COVID-19
-10%
portes grátis
Biomedical Innovations to Combat COVID-19
Comas-Garcia, Mauricio; Gonzalez-Ortega, Omar; Rosales-Mendoza, Sergio
Elsevier Science & Technology
10/2021
410
Mole
Inglês
9780323902489
15 a 20 dias
820
Descrição não disponível.
1. Basic virological aspects of SARS-CoV-22. Fundamental aspects of the structural biology of Coronaviruses3. Introduction to the SARS-CoV-2/COVID-19 epidemiology4. Structural biology of the SARS-Cov 2 replisome: evolutionary and therapeutic implications5. Clinical progression of patients with COVID-19: The impact of the pandemic in Latin America6. Overview of the immune response against SARS-CoV-27. Viral-vectored vaccines against SARS-CoV-28. RNA-based vaccines against SARS-CoV-29. Particulate vaccines against SARS-CoV-210. VLPs-based vaccines against SARS-CoV-211. Innovative recombinant protein-based vaccines against SARS-CoV-212. SARS-CoV-2 Vaccines: Current Trends and Prospects of Developing Plant-Derived Vaccines13. Nanobodiestargeting SARS-CoV-214. 2D materials and van der Waals heterostructures platforms for advanced sensing of COVID-1915. Microfluidic-based biosensor for SARS-CoV-2 antibodies16. Antivirals based on nanomaterials against SARS-CoV-217. The potential of drug delivery nanosystems to treat COVID-1918. The role of traditional medicine in the fight against SARS-CoV-2
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Acute respiratory distress syndrome; Antiviral agent; Antiviral drugs; Antiviral effect; COVID-19; Clinical stages; Clinical trials; Clustering symptoms; Human health; Immunity; Lethality; Nanobodies; Nanomaterial; Nanovaccines; Pandemic; Particulate vaccine; Pneumonia; RNA virus; Reverse transcriptase-polymerase chain reaction; SARS-CoV-2; SARS-CoV-2; Severe acute respiratory syndrome; VLP; Vaccines; Vaccines; Vaccines; Viral-vectored; Virus; World Health Organization
1. Basic virological aspects of SARS-CoV-22. Fundamental aspects of the structural biology of Coronaviruses3. Introduction to the SARS-CoV-2/COVID-19 epidemiology4. Structural biology of the SARS-Cov 2 replisome: evolutionary and therapeutic implications5. Clinical progression of patients with COVID-19: The impact of the pandemic in Latin America6. Overview of the immune response against SARS-CoV-27. Viral-vectored vaccines against SARS-CoV-28. RNA-based vaccines against SARS-CoV-29. Particulate vaccines against SARS-CoV-210. VLPs-based vaccines against SARS-CoV-211. Innovative recombinant protein-based vaccines against SARS-CoV-212. SARS-CoV-2 Vaccines: Current Trends and Prospects of Developing Plant-Derived Vaccines13. Nanobodiestargeting SARS-CoV-214. 2D materials and van der Waals heterostructures platforms for advanced sensing of COVID-1915. Microfluidic-based biosensor for SARS-CoV-2 antibodies16. Antivirals based on nanomaterials against SARS-CoV-217. The potential of drug delivery nanosystems to treat COVID-1918. The role of traditional medicine in the fight against SARS-CoV-2
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Acute respiratory distress syndrome; Antiviral agent; Antiviral drugs; Antiviral effect; COVID-19; Clinical stages; Clinical trials; Clustering symptoms; Human health; Immunity; Lethality; Nanobodies; Nanomaterial; Nanovaccines; Pandemic; Particulate vaccine; Pneumonia; RNA virus; Reverse transcriptase-polymerase chain reaction; SARS-CoV-2; SARS-CoV-2; Severe acute respiratory syndrome; VLP; Vaccines; Vaccines; Vaccines; Viral-vectored; Virus; World Health Organization
